BioCentury
ARTICLE | Clinical News

Aastrom CPS automated cell production system data

December 11, 1995 8:00 AM UTC

The company reported results from 10 patients showing safety and lack of toxicity when the system for culturing stem cells was used to augment autologous bone marrow transplants (BMT) after marrow-ablating chemotherapy for breast cancer.

Accelerated recovery of bone marrow and engrafting within narrow time ranges also was suggested by the results, compared to historical controls receiving the same chemotherapy and autologous marrow. ...